National Vision Holdings Inc. (EYE)
National Vision Holdings Inc (EYE) Q2 2024 Earnings Call Transcript
National Vision Holdings Inc (NASDAQ:EYE ) Q2 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Tamara Gonzalez - IR Reade Fahs - CEO, President & Director Melissa Rasmussen - Senior VP & CFO Conference Call Participants Michael Lasser - UBS Simeon Siegel - BMO Capital Markets Anthony Chukumba - Loop Capital Markets Kate McShane - Goldman Sachs Zach Fadem - Wells Fargo Simeon Gutman - Morgan Stanley Brian Tanquilut - Jefferies Brandon Cheatham - Citigroup Adrienne Yih - Barclays Dylan Carden - William Blair Operator Good day, and thank you for standing by. Welcome to the Q2 2024 National Vision Holdings Earnings Conference Call.
National Vision (EYE) Q2 Earnings Beat Estimates
National Vision (EYE) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.17 per share a year ago.
Should Value Investors Buy National Vision (EYE) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EYE vs. PODD: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either National Vision (EYE) or Insulet (PODD). But which of these two stocks presents investors with the better value opportunity right now?
Are Investors Undervaluing National Vision (EYE) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Strength Seen in National Vision (EYE): Can Its 7.2% Jump Turn into More Strength?
National Vision (EYE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EYE or SYK: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of National Vision (EYE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
National Vision (EYE) Gains Market Share Despite Macro Woes
National Vision (EYE) continues to execute core growth initiatives and further invest in strengthening competitive advantages.
3 Retail Stocks That Could Collapse in the E-Commerce Shakeout
With multiple factors in play, a major shakeout is due in the e-commerce space. The rise of AI advances in logistics tech and the post-pandemic norm will play a huge role in driving e-commerce moving forward.
